AR124243A2 - PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST ESOPHAGEAL AND OTHER CANCERS - Google Patents
PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST ESOPHAGEAL AND OTHER CANCERSInfo
- Publication number
- AR124243A2 AR124243A2 ARP210103365A ARP210103365A AR124243A2 AR 124243 A2 AR124243 A2 AR 124243A2 AR P210103365 A ARP210103365 A AR P210103365A AR P210103365 A ARP210103365 A AR P210103365A AR 124243 A2 AR124243 A2 AR 124243A2
- Authority
- AR
- Argentina
- Prior art keywords
- peptides
- present
- relates
- tumor
- cancers
- Prior art date
Links
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
La presente invención se relaciona con péptidos, proteínas, ácidos nucleicos y células para usar en métodos inmunoterapéuticos. En particular, la presente invención se relaciona con la inmunoterapia de cáncer. La presente invención además se relaciona con epitopes péptidos de células T asociados a tumor, solos o en combinación con otros péptidos asociados a tumor que por ejemplo pueden servir como ingredientes farmacéuticos activos de composiciones de vacuna que estimulan respuestas inmunológicas antitumorales, a para estimular a células T ex vivo y transferirlas a los pacientes. Los péptidos unidos a las moléculas del complejo mayor de histocompatibilidad (MHC), o los péptidos como tal, también pueden ser blancos de anticuerpos, receptores solubles de células Y, y de otras moléculas de unión.The present invention relates to peptides, proteins, nucleic acids, and cells for use in immunotherapeutic methods. In particular, the present invention relates to cancer immunotherapy. The present invention further relates to tumor-associated T-cell peptide epitopes, alone or in combination with other tumor-associated peptides that, for example, can serve as active pharmaceutical ingredients of vaccine compositions that stimulate antitumor immune responses, to stimulate cells T ex vivo and transfer them to patients. Peptides bound to major histocompatibility complex (MHC) molecules, or peptides themselves, can also be targets of antibodies, soluble Y cell receptors, and other binding molecules.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562188870P | 2015-07-06 | 2015-07-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR124243A2 true AR124243A2 (en) | 2023-03-01 |
Family
ID=59981555
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP160102025A AR105252A1 (en) | 2015-07-06 | 2016-07-04 | PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST ESOPHAGIC CANCER AND OTHER CANCER |
| ARP210103365A AR124243A2 (en) | 2015-07-06 | 2021-12-03 | PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST ESOPHAGEAL AND OTHER CANCERS |
| ARP210103364A AR124242A2 (en) | 2015-07-06 | 2021-12-03 | PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST ESOPHAGEAL CANCER AND OTHER CANCERS |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP160102025A AR105252A1 (en) | 2015-07-06 | 2016-07-04 | PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST ESOPHAGIC CANCER AND OTHER CANCER |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP210103364A AR124242A2 (en) | 2015-07-06 | 2021-12-03 | PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST ESOPHAGEAL CANCER AND OTHER CANCERS |
Country Status (1)
| Country | Link |
|---|---|
| AR (3) | AR105252A1 (en) |
-
2016
- 2016-07-04 AR ARP160102025A patent/AR105252A1/en unknown
-
2021
- 2021-12-03 AR ARP210103365A patent/AR124243A2/en unknown
- 2021-12-03 AR ARP210103364A patent/AR124242A2/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR105252A1 (en) | 2017-09-20 |
| AR124242A2 (en) | 2023-03-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO2017009616A2 (en) | Peptides and combination of peptides and scaffolds for immunotherapy against renal cell carcinoma (rcc) and other cancers | |
| AR127119A2 (en) | NOVEL PEPTIDES AND COMBINATIONS OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS | |
| CL2021000979A1 (en) | New peptides and peptide combinations for use in immunotherapy against esophageal and other cancers. (divisional application no. 201703361) | |
| CO2018002202A2 (en) | Peptides and combinations of peptides for immunotherapy against prostate cancer and other types of cancer | |
| CO2017008902A2 (en) | Peptides and new combinations of peptides for immunotherapy against lung cancer, including amicrocytic lung cancer and other types of cancer | |
| PE20181164A1 (en) | NEW PEPTIDES, PEPTIDE COMBINATIONS AND SUPPORTS FOR USE IN THE IMMUNOTHERAPEUTIC TREATMENT OF VARIOUS TYPES OF CANCERS | |
| CO2017012891A2 (en) | Peptides and combinations of peptides for immunotherapy against ovarian cancer and other types of cancer | |
| CR20180460A (en) | TREATMENT AGAINST UTERUS CANCER | |
| PE20180174A1 (en) | NEW CELLULAR EPITOPES AND NEW COMBINATIONS OF CELLULAR EPITOPS FOR USE IN THE IMMUNOTHERAPY OF MYELOMA AND OTHER TYPES OF CANCER | |
| CO2018000245A2 (en) | Peptides and combinations of peptides for immunotherapy against pancreatic cancer and other types of cancer | |
| CR20190388A (en) | Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers | |
| CR20220115A (en) | NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS (Div. 2017-522) | |
| CO2018002902A2 (en) | Peptides and peptide combinations for the immunotherapeutic treatment of various types of cancer | |
| CL2024000530A1 (en) | Peptides and combinations, their use in immunotherapy against lung cancer and other cancers | |
| CO2019012071A2 (en) | Peptides and peptide combinations for use in immunotherapy against leukemia and other cancers | |
| CL2023001324A1 (en) | Peptides, combinations, cells for immunotherapy against bladder cancer and other cancers | |
| CR20190094A (en) | Novel peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers | |
| CO2017009101A2 (en) | Peptides and peptide combination | |
| CO2018006022A2 (en) | Cellular epitopes and combinations of cell epitopes for immunotherapy of myeloma and other types of cancer | |
| CO2017010830A2 (en) | Peptides and combinations of peptides and supports | |
| CO2017003772A2 (en) | Peptides and peptide combination for use in immunotherapy against hepatocellular carcinoma (chc) and other cancers | |
| AR124243A2 (en) | PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST ESOPHAGEAL AND OTHER CANCERS | |
| AR122218A2 (en) | PEPTIDES AND SUPPORTS USEFUL IN THE IMMUNOTHERAPEUTIC TREATMENT OF VARIOUS TYPES OF CANCER | |
| AR111370A1 (en) | PEPTIDES AND COMBINATIONS OF PEPTIDES FOR USE IN IMMUNOTHERAPIES AGAINST LEUKEMIA AND OTHER CANCER | |
| AR111459A1 (en) | PEPTIDES AND COMBINATIONS OF THE SAME FOR USE IN AN IMMUNOTHERAPY AGAINST CANCER |